Laboratory Corporation of America Holdings (LH) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
Total Cash From Operating Activities Chart for Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings (LH) operating cash flow for FY2025 was USD 1.6B, a 3.4% change from FY2024. Laboratory Corporation of America Holdings's operating cash flow grew from USD 71.8M in 1989 to USD 1.6B in 2025 (2184.8% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of -5.1%, 10-year CAGR of 5.3%, 20-year CAGR of 5.4%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $25.40B
- Implied Share Price
- $313.96
- Enterprise Value
- $31.89B
- Revenue (TTM)
- $14.35B
- EBITDA
- $2.32B
- Profit Margin
- 6.99%
- Trailing P/E
- 25.97
- Forward P/E
- 17.21
- Price/Book (MRQ)
- 2.94
- Price/Sales (TTM)
- 1.79
- EV/EBITDA
- 14.78
- EV/Revenue
- 2.22
- Dividend Yield
- 0.92%
- Book Value
- $106.39
- Free Cash Flow (FY2025)
- $1.21B
- Free Cash Flow Yield
- 4.75%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.